In vivo immunoadsorption of antipig antibodies in baboons using a specific Galα1-3Gal column

Transplantation

Volumn 62, Issue 10, 1996, Pages 1379-1384

  Taniguchi, S ^a,f   Neethling, F A ^a   Korchagina, E Y ^b   Bovin, N ^b   Ye, Y ^a   Kobayashi, T ^a   Niekrasz, M ^c   Li, S ^a   Koren, E ^d   Oriol, R ^e   Cooper, D K C ^a,g  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e INSERM   (France)

^f NARA MEDICAL UNIVERSITY   (Japan)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BABOON; CYTOTOXICITY; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SERUM; SPLENECTOMY; SWINE;

EID: 2442758069     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611270-00001     Document Type: Article

References (32)

1. Bannett AD, McAlack RF, Raja R, Baquero A, Morris M. Experiences with known ABO-mismatched renal transplants. Transplant Proc 1987; 19: 4543.
2. Good H, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures which bind human anti-porcine antibodies: implications for discordant xenografting in man. Transplant Proc 1992; 24: 559.
3. Cooper DKC. Depletion of natural antibodies in non-human primates - a step towards successful discordant xenografting in man. Clin Transplant 1992; 6: 178.
4. Cooper DKC. Is xenotransplantation a realistic clinical option? Transplant Proc 1992; 24: 2392.
5. Cooper DKC, Good AH, Malcolm AJ, et al. Specific intravenous carbohydrate therapy - a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting. Transplant Proc 1993; 25: 377.
6. Cooper DKC, Good AH, Koren E, et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993; 1: 198.
7. Cooper DKC, Koren E, Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31.
8. Koren E, Neethling FA, Koscec M, et al. In vitro model for hyperacute rejection of xenogeneic cells. Transplant Proc 1994; 26: 1166.
9. Kujundzic M, Koren E, Neethling FA, et al. Variability of anti-αGal antibodies in human serum and their relation to serum cytotoxicity against pig cells. Xenotransplantation 1994; 1: 58.
10. Neethling FA, Kujundzic M, Koren E, Cooper DKC. Variability of anti-αGal antibodies in human and baboon sera. J Heart Transplant 1995; 14: S72.
11. Neethling FA, Koren E, Ye Y, et al. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides. Transplantation 1994; 57: 959.
12. Neethling FA, Koren E, Oriol R, et al. Immunoadsorption of natural antibodies from human serum by affinity chromatography utilizing specific carbohydrates protects pig cells from cytotoxic destruction. Transplant Proc 1994; 26: 1378.
13. Ye Y, Neethling FA, Niekrasz M, et al. Evidence that intravenously administered α-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58: 330.
14. Kobayashi T, Taniguchi S, Ye Y, et al. Prolongation of graft survival following pig-to-baboon heart transplantation by cobra venom factor (CVF) without natural antibody depletion. Transplant Proc (in press).
15. Rieben R, Von Allmen E, Korchagina EY, et al. Detection, immunoabsorption, and inhibition of cytotoxic activity of anti-αGal antibodies using newly developed substances with synthetic Galα1-3Gal disaccharide epitopes. Xenotransplantation 1995; 2: 98.
16. Cooper DKC. Allo- and xenotransplantation in non-human primates. Minerva Chir 1991; 46: 107.
17. Cooper DKC, Ye Y, Niekrasz M. Heart transplantation in primates. In: Cramer DV, Podesta L, Makowka L, eds. Handbook of animal models in transplantation research. Boca Raton, FL: CRC, 1993: 173.
18. Korchagina EY, Bovin NV. Synthesis of spacer trisaccharides with blood group A and B specificities, their fragments and structural analogues. Sov J Bioorg Chem 1992; 18: 153.
19. Bovin NV. Sugar-polyacrylamide conjugates as probes for cell lectins. In: Gabius H-J, Gabius S, eds. Lectins and glycobiology. Heidelberg: Springer, 1993: 23.
20. Bovin NV, Korchagina EY, Zemlyanukhina TV, et al. Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamides. Glycoconj J 1993; 10: 142.
21. Stark JH, Smit JA, Gridelli B. Sensitivity of baboon lymphocytes to cyclosporin A and FK506: relative resistance of alloactivated cells to CyA. Transplant Int 1994; 7: 372.
22. Koren E, Neethling FA, Richards S, et al. Binding and specificity of major immunoglobulin classes of preformed human anti-pig heart antibodies. Transplant Int 1993; 6: 351.
23. Li S, Yeh J-C, Cooper DKC, Cummings RD. Inhibition of human anti-αGal IgG by oligosaccharides derived from porcine stomach mucin. Xenotransplantation 1995; 2: 279.
24. Van De Stadt J, Vendeville V, Weill B, et al. Discordant heart xenografts in the rat: additional effect of plasma exchange and cyclosporine, cyclophosphamide, or splenectomy in delaying hyperacute rejection. Transplantation 1988; 45: 514.
25. Mieles L, Ye Y, Luo Y, et al. Auxiliary liver allografting and xenografting in the non-human primate. Transplantation 1995; 59: 1670.
26. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
27. Sablinski T, Latinne D, Gianello P, et al. Xenotransplantation of pig kidneys to nonhuman primates: I. Development of the model. Xenotransplantation 1995; 2: 264.
28. Neethling FA, Joziasse D, Bovin N, Cooper DKC, Oriol R. The reducing end of αGal oligosaccharides contributes to their efficiency in blocking natural antibodies of human and baboon sera. Transplant Int 1996; 9: 98.
29. Cairns T, Lee J, Goldberg L, et al. Polymorphism within the human IgG anti-pig repertoire. (Presented to the British Transplantation Society, 1995.
30. Cooper DKC, Ye Y, Kehoe M, et al. A novel approach to "neutralization" of preformed antibodies: cardiac allotransplantation across the ABO-blood group barrier as a paradigm of discordant xenotransplantation. Transplant Proc 1992; 25: 566.
31. Cooper DKC, Ye Y, Niekrasz M, et al. Specific intravenous carbohydrate therapy - a new concept in inhibiting antibody-mediated rejection: experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 1993; 56: 769.
32. Platt JL, Thurman MA, Noreen HJ, et al. An ELISA assay for xenoreactive antibodies. Transplantation 1990; 49: 1000.